Patents by Inventor Subhas Chandra Gupta

Subhas Chandra Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060057234
    Abstract: The invention relates to a new use of a non-alkaloid compound that is plant derived glycoside ‘glycyrrhizin’ as a highly potent bio-enhancer of activity and availability of antibiotics and other drugs including anti-infective and anticancer agents. The molecule of invention facilitates the absorption/uptake of antibiotics and other molecules across the cell membrane in plant and animal cells as well as Gram-positive and Gram-negative bacteria and therefore can be used as a drug facilitator or bioenhancer molecule to increase the affectivity of drugs and nutraceutical agents. The compound having no antimicrobial or cytotoxic activity of its own, is a safe candidate to reduce the drug dosage towards circumventing the problem of drug resistance and the other side effects in anti-infective and anti-cancer therapies.
    Type: Application
    Filed: November 9, 2005
    Publication date: March 16, 2006
    Inventors: Suman Preet Singh Khanuja, Sushil Kumar, Jai Shankar Arya, Ajit Kumar Shasany, Monika Singh, Soumya Awasthi, Subhas Chandra Gupta, Mahendra Pandurang Darokar, Laiq-Ur Rahman
  • Patent number: 6979471
    Abstract: The invention relates to a new use of a non-alkaloid compound that is plant derived glycoside ‘glycyrrhizin’ as a highly potent bio-enhancer of activity and availability of antibiotics and other drugs including anti-infective and anticancer agents. The molecule of invention facilitates the absorption/uptake of antibiotics and other molecules across the cell membrane in plant and animal cells as well as Gram-positive and Gram-negative bacteria and therefore can be used as a drug facilitator or bioenhancer molecule to increase the affectivity of drugs and nutraceutical agents. The compound having no antimicrobial or cytotoxic activity of its own, is a safe candidate to reduce the drug dosage towards circumventing the problem of drug resistance and the other side effects in anti-infective and anti-cancer therapies.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: December 27, 2005
    Assignee: Council of Scientific and Industrial Research
    Inventors: Suman Preet Singh Khanuja, Sushil Kumar, Jai Shankar Arya, Ajit Kumar Shasany, Monika Singh, Soumya Awasthi, Subhas Chandra Gupta, Mahendra Pandurang Darokar, Laiq Ur Rahman